[1]张鹏 刘金波 王宏宇.静脉血栓栓塞症患者血浆生物标志物与肺栓塞的相关性研究[J].心血管病学进展,2022,(4):365-370.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.019]
　ZHANG Peng,LIU Jinbo,WANG Hongyu.Correlation Between Plasma Biomarkers and Pulmonary Embolism in?atients with Venous Thromboembolism[J].Advances in Cardiovascular Diseases,2022,(4):365-370.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.019]
点击复制

静脉血栓栓塞症患者血浆生物标志物与肺栓塞的相关性研究()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年4期
页码:
365-370
栏目:
论著
出版日期:
2022-04-25

文章信息/Info

Title:
Correlation Between Plasma Biomarkers and Pulmonary Embolism in?atients with Venous Thromboembolism
作者:
张鹏1; 2 刘金波 1; 3 王宏宇 1; 3; 4
(1.北京大学首钢医院血管医学中心,北京 100144;2.国家卫生健康委职业安全卫生研究中心,北京 102308;3.北京大学医学部血管健康研究中心,北京 100144;4.分子心血管学教育部重点实验室(北京大学),北京 100191)
Author(s):
ZHANG Peng1; 2;  LIU Jinbo1; 3;  WANG Hongyu1; 3; 4
?1.Department of Vascular Medicine,Peking University Shougang Hospital,Beijing 100144,China; 2.National Center For Occupational Safety and Health,Beijing 102308,China;3.Vascular Health Research Center of Peking University Health Science Center,Beijing 100144,China;4.Key Laboratory of Molecular Cardiovascular Sciences (Peking University),Ministry of Education,Beijing 100144,China)
关键词:
静脉血栓栓塞症; 肺栓塞; 血浆生物标志物
Keywords:
Venous thromboembolism;  Pulmonary embolism;  Plasma biomarkers
DOI:
10.16806/j.cnki.issn.1004-3934.2022.04.019
摘要:
目的 探讨静脉血栓栓塞症（VTE）患者血浆生物标志物与肺栓塞（PE）的关联性。 方法 选取2016年 1月—2019年12月在北京大学首钢医院血管医学中心确诊VTE的348例患者作为研究对象，根据是否患有PE，分为无PE组和PE组，分别统计并比较两组患者的一般临床资料，检测并比较两组患者的D-二聚体、脑钠肽、C反应蛋白、肌钙蛋白I和中性粒细胞/淋巴细胞比值等血浆生物标志物水平。再根据肺栓塞严重指数评分和简化肺栓塞严重指数评分将PE组分成低危组和中高危组，比较两组患者的血浆生物标志物水平。行Spearman相关性分析，分析各生物标志物与PE发生与否以及其疾病危险程度的相关性。行logistic回归分析，分析各生物标志物与PE的关系。结果 （1）无PE组和PE组患者收缩压、舒张压和心率有统计学差异（P＜0.05）；血浆生物标志物D-二聚体、C反应蛋白、肌钙蛋白I和平均血小板体积有统计学差异（P＜0.05）。（2）PE组，低危组、中高危组的血浆生物标志物水平比较，脑钠肽、中性粒细胞/淋巴细胞比值和尿素氮有统计学差异（P＜0.05）。（3）VTE患者的血浆生物标志物与是否发生PE、PE疾病危险分层的相关性分析，D-二聚体、脑钠肽、C反应蛋白、红细胞容积分布宽度、平均血小板体积与是否发生PE呈正相关（r=0.444，P＜0.001；r=0.219，P=0.001；r=0.313，P＜0.001；r=0.129，P=0.047；r=0.185，P=0.004），肌钙蛋白I与是否发生PE呈负相关（r=－0.181，P=0.042）；脑钠肽、中性粒细胞/淋巴细胞比值、尿素氮与PE疾病危险分层呈正相关（r=0.358，P=0.003；r=0.259，P=0.028；r=0.345，P=0.002）。（4）经logistic回归分析，VTE患者的血浆生物标志物中D-二聚体、脑钠肽、C反应蛋白、肌钙蛋白I、红细胞容积分布宽度、平均血小板体积与PE具有显著相关性。结论 VTE患者中，部分血浆生物标志物与是否发生PE及病情危险程度有关，可辅助临床应用。
Abstract:
Objective To investigate the correlation between plasma biomarkers and pulmonary embolism (PE) in patients with venous thromboembolism (VTE). Methods A total of 348 patients diagnosed for VTE in vascular medical center of Shougang Hospital of Peking University from January 2016 to December 2019 were enrolled as research objects, and divided into non-PE and PE groups. The general clinical data were collected. Plasma biomarker levels of D-dimer, brain natriuretic peptide (BNP), C-reactive protein (CRP), troponin I and neutrophil-to-lymphocyte ratio (NLR) were detected and compared. PE patients with different pulmonary embolism severity index score and simplified pulmonary embolism severity index score were redivided into low-risk and medium high-risk groups to compare plasma biomarker levels. The correlations of biomarkers with PE occurrence and risk stratification were determined by Spearman analysis. The relationship between biomarkers and PE was calculated by logistic regression analysis. Results (1)There were significant differences not only in systolic blood pressure, diastolic blood pressure and heart rate ( P＜0.05), but also in levels of D-dimer, CRP, troponin I and mean platelet volume (MPV) between non-PE and PE groups (P＜0.05). (2)Likewise, the differences were significant in levels of BNP, NLR and urea nitrogen among PE, low-risk and medium-risk groups ( P＜0.05). (3)Spearman analysis indicated D-dimer, BNP, CRP, erythrocyte volume distribution width and MPV were positively correlated with PE occurrence ( r=0.444,P＜0.001;r=0.219,P=0.001;r=0.313,P＜0.001;r=0.129,P=0.047;r=0.185,P=0.004), while troponin I showed a negative correlation with PE occurrence (r=－0.181,P=0.042). Levels of BNP, NLR and urea nitrogen were positively correlated with PE risk stratification (r=0.358,P=0.003;r=0.259, P=0.028;r=0.345,P=0.002). (4)Logistic regression analysis showed levels of D-dimer, BNP, CRP, troponin I, erythrocyte volume distribution width and MPV showed significant correlations with PE. Conclusion The correlations of some plasma biomarkers with PE occurrence and risk stratification in patients with VTE may help to their clinical applications.

参考文献/References:


[1]中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志,2020,35(9):833-854.

[2]Konstantinides SV,Meyer G,Becattini C,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)[J]. Eur Heart J,2020,41(4):543-603.

[3]Heit JA,Spencer FA,White RH. The epidemiology of venous thromboembolism[J]. J Thromb Thrombolysis,2016,41(1):3-14.

[4] Stevens H,Peter K,Tran H,et al. Predicting the risk of recurrent venous thromboembolism:current challenges and future opportunities[J]. J Clin Med,2020,9(5):1582.

[5]晏露,李欣,柳志红. 不同生物标志物在急性肺血栓栓塞症中的应用价值[J]. 心血管病学进展,2019,40(5):687-691.

[6]诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华健康管理学杂志,2017,11(1):7-28.

[7]中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南（第三版）[J]. 《中国血管外科杂志（电子版）》,2017,9(4):250-257.

[8]Wells PS,Ihaddadene R,Reilly A,et al. Diagnosis of venous thromboembolism:20 years of progress[J]. Ann Intern Med,2018,168(2):131-140.

[9]王峰,张伟华,刘占祥. BNP、TNI水平变化与肺栓塞相关性分析[J]. 国际呼吸杂志,2018,38(1):53-55.

[10]Mahajan A,Wun T. Biomarkers of cancer-associated thromboembolism[J]. Cancer Treat Res,2019,179:69-85.

[11]Puurunen MK,Enserro D,Xanthakis V,et al. Biomarkers for the prediction of venous thromboembolism in the community[J]. Thromb Res,2016,145:34-39.

[12]Bhat TM,Atari ME,Garcia LA. Neutrophil lymphocyte ratio in peripheral vascular disease:a review[J]. Expert Rev Cardiovasc Ther,2016,14(7):871-875.

[13]Galliazzo S,Nigro O,Bertù L,et al. Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism:a systematic review and meta-analysis of the literature[J]. Intern Emerg Med,2018,13(4):603-608.

[14]Ozsu S,Abul Y,Gunaydin S,et al. Prognostic value of red cell distribution width in patients with pulmonary embolism[J]. Clin Appl Thromb Hemost,2014,20(4):365-370.

[15]Kostrubiec M,?abyk A,Pedowska-W?oszek J,et al. Mean platelet volume predicts carry death in acute pulmonary embolism[J]. Heart,2010,96(6):460-465．

[16]Samuelson Bannow BT,Konkle BA. Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies:a review[J]. Thromb Res,2018,163:138-145.

相似文献/References:

[1]朱洪基,余建群,彭礼清.心电门控双源CTPA评价急性肺栓塞及其右心室功能[J].心血管病学进展,2019,(6):955.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.029]
　ZHU Hongji,YU Jianqun,PENG Liqing.Evaluation of Acute Pulmonary Embolism and Its Right Ventricular Function by ECG Gated Dual-source CTPA[J].Advances in Cardiovascular Diseases,2019,(4):955.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.029]
[2]张鹏 刘金波 王宏宇.不同生物标志物在静脉血栓栓塞症中应用价值的研究进展[J].心血管病学进展,2021,(11):978.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
　ZHANG Peng,LIU Jinbo,WANG Hongyu.Application Value of Different Biomarkers in Venous Thromboembolism[J].Advances in Cardiovascular Diseases,2021,(4):978.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
[3]杨晴 梁岩.利伐沙班预防血栓的研究进展[J].心血管病学进展,2022,(10):932.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.016]
　YANG Qing,LIANG Yan.Rivaroxaban in The Prevention of Thrombosis[J].Advances in Cardiovascular Diseases,2022,(4):932.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.016]
[4]朱栋 何翔 李国平.基于Virchow三要素浅谈环境污染与肺栓塞疾病[J].心血管病学进展,2022,(11):984.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.005]
　ZHU Dong,HE Xiang,LI Guoping.Discussing Environmental Pollution and Pulmonary Embolic Disease Based on?irchows Triad[J].Advances in Cardiovascular Diseases,2022,(4):984.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.005]
[5]李梦依 刘英杰 齐灵垚 秦地茂.孟德尔随机化探讨三甲胺N-氧化物及其前体与静脉血栓栓塞的因果关系[J].心血管病学进展,2023,(8):764.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.020]
　Li Mengyi,Liu YingjieQi LingyaoQin Dimao.Mendelian Randomization Exploring the Causality of Trimethylamine N-oxide and Its Precursors with Venous Thromboembolism[J].Advances in Cardiovascular Diseases,2023,(4):764.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.020]
[6]王一佳 黄志华 高璐阳 赵智慧 赵青 罗勤 柳志红.人工智能在肺血管疾病诊治中的研究进展[J].心血管病学进展,2024,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.002]
　WANG Yijia,HUANG Zhihua,GAO Luyang,et al.Artificial Intelligence in Diagnosis and Treatment of Pulmonary Vascular Diseases[J].Advances in Cardiovascular Diseases,2024,(4):3.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.002]
[7]丁兆慧 奚群英.双能量CT成像技术在肺血管疾病中的应用进展[J].心血管病学进展,2024,(1):27.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.008]
　DING Zhaohui,XI Qunying.Dual-Energy CT Imaging in Pulmonary Vascular Diseases[J].Advances in Cardiovascular Diseases,2024,(4):27.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.008]
[8]焦小净 龚娟妮 邝土光 李积凤 张一笑 杨媛华.慢性阻塞性肺疾病急性加重期合并肺栓塞的患病率及临床特征分析[J].心血管病学进展,2024,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.021]
　JIAO Xiaojing,G ONG Juanni,K UANG Tuguang,et al.Incidence Rate and Clinical Characteristics of Pulmonary Embolism in Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Advances in Cardiovascular Diseases,2024,(4):84.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.021]

更新日期/Last Update: 2022-05-13